Clinical Trial

A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection

Name: A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection — clinical trial record (NCT07489482)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a randomized, parallel, open-label Phase I clinical trial aimed at comparing the bioavailability and safety of different specifications of SHR-3167 injection, with healthy subjects as the research subjects.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-30

Trial Details

NCT Number	NCT07489482
Lead Sponsor	Jiangsu HengRui Medicine Co., Ltd.
Conditions	Diabetes Mellitus
Enrollment	60 participants
Start Date	2026-04-02
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-29